We're attending BIO China 2026 in Guangzhou, China, on 12–14 March 2026.

Bringing together global leaders in biotechnology, life sciences, and biopharmaceutical innovation, BIO China serves as a major platform for scientific exchange, strategic partnerships, and the advancement of cutting‑edge technologies shaping the future of healthcare.

Representing Richmond Pharmacology:

  • Stephen Wilkinson, Business Development Manager

Our Focus at the Exhibition

  • Emerging biotechnology platforms and therapeutic innovations
  • Global clinical development strategies and regulatory pathways
  • Strengthening cross‑border collaboration and partnering opportunities
  • Advances in early‑phase clinical trial design
  • Building sustainable scientific and commercial relationships in the Asia‑Pacific region

Connect With Us

If you are attending BIO China 2026 and would like to explore collaboration or development opportunities:

📧 fasteranswers@richmondpharmacology.com

Find out more here: BIOCHINA

Latest news

Richmond Pharmacology Appoints John Hotti as Chief Technology Officer

April 22, 2026
Richmond Pharmacology is pleased to announce the appointment of John Hotti as Chief Technology Officer (CTO), strengthening the company’s leadership in technology-enabled clinical research.
Read more

Events

Clinical Trials Innovation Programme

10 - 11 February 2026
Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.
View event